Search hospitals > North Carolina > Wilmington
Novo Nordisk Investigational Site
Claim this profileWilmington, North Carolina 28401
Global Leader in Diabetes Mellitus
Global Leader in Type 2 Diabetes
Conducts research for Diabetes
Conducts research for Haemophilia A, Haemophilia B, Obesity
Conducts research for Bleeding Disorder
270 reported clinical trials
0 medical researchers
Summary
Novo Nordisk Investigational Site is a medical facility located in Wilmington, North Carolina. This center is recognized for care of Diabetes Mellitus, Type 2 Diabetes, Diabetes, Haemophilia A, Haemophilia B, Obesity, Bleeding Disorder and other specialties. Novo Nordisk Investigational Site is involved with conducting 270 clinical trials across 94 conditions. There are 0 research doctors associated with this hospital, such as .Area of expertise
1Diabetes Mellitus
Global LeaderStage II
Stage I
2Type 2 Diabetes
Global LeaderStage II
Stage I
Top PIs
Clinical Trials running at Novo Nordisk Investigational Site
Heart Failure
Haemophilia
Haemophilia A, Haemophilia B, Obesity
Ocular Inflammation and Pain
Ziltivekimab
for Heart Failure
This trial is testing ziltivekimab to see if it can help people with heart failure and inflammation by reducing inflammation and improving heart function.
Recruiting1 award Phase 37 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novo Nordisk Investigational Site?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.